Skip to content

Author

Erin M. O'Brien

We have 1 of 8 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Nanoconjugate Strategy Integrating Immunogenic Cell Death Induction and Innate Immune Activation for Potent Anti‐Cancer Immunity

A carrier‐free peptide–cyclic dinucleotide (CDN) nanoconjugate (PCN) is developed that co‐activates immunogenic cell death (ICD) in tumors and stimulator of interferon genes (STING) signaling in DCs and broadly reprogrammed the tumor microenvironment toward anti‐tumor immunity.

Teng-Yu He, Alexander M. Cryer, Daniela Simental Lopez et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.